Alan Fuhrman

Insider Reports History

Entity
Individual
Location
C/O Ambit Biosciences Corporation, 11080 Roselle Street, San Diego, CA
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Fuhrman:

Insider Reports Filed by Alan Fuhrman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TYRA Tyra Biosciences, Inc. Oct 30, 2024 1 $152K 4 Nov 1, 2024 Chief Financial Officer
TYRA Tyra Biosciences, Inc. Sep 13, 2024 1 $11.9K 4 Sep 17, 2024 Chief Financial Officer
TYRA Tyra Biosciences, Inc. Aug 14, 2024 1 $0 4 Aug 16, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
SWTX SpringWorks Therapeutics, Inc. May 16, 2024 2 $0 4 May 17, 2024 Director
TYRA Tyra Biosciences, Inc. Mar 15, 2024 1 $11.6K 4 Mar 19, 2024 Chief Financial Officer
TYRA Tyra Biosciences, Inc. Sep 15, 2023 1 $18.3K 4 Sep 19, 2023 Chief Financial Officer
TYRA Tyra Biosciences, Inc. Jul 28, 2023 1 $0 4 Aug 1, 2023 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
SWTX SpringWorks Therapeutics, Inc. May 24, 2023 2 $0 4 May 25, 2023 Director
TYRA Tyra Biosciences, Inc. Jan 1, 2023 2 $0 4 Jan 3, 2023 Chief Financial Officer
TYRA Tyra Biosciences, Inc. Jan 1, 2023 0 $0 3 Jan 3, 2023 Chief Financial Officer
CMPI Checkmate Pharmaceuticals, Inc. May 31, 2022 3 $0 4 May 31, 2022 Director
ESPR Esperion Therapeutics, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
SWTX SpringWorks Therapeutics, Inc. May 19, 2022 2 $0 4 May 20, 2022 Director
CMPI Checkmate Pharmaceuticals, Inc. Oct 27, 2021 1 $0 4 Oct 29, 2021 Interim President and Chief Executive Officer, Director
CMPI Checkmate Pharmaceuticals, Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director
ESPR Esperion Therapeutics, Inc. May 27, 2021 1 $0 4 May 28, 2021 Director
SWTX SpringWorks Therapeutics, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director